GRAIL, Inc. (GRAL) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $45.00K; Additional Paid in CapitalUSD $12.96B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.84M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $41.00K; Additional Paid in CapitalUSD $12.80B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.87M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $40.00K; Additional Paid in CapitalUSD $12.79B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.65M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $36.00K; Additional Paid in CapitalUSD $12.35B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.46M.
GRAIL, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $45.00K | $12.96B | $1.84M | $-10.42B | $2.54B | 3 month · $19.56M |
| 2026-03-31 | $0.00 | $41.00K | $12.80B | $1.87M | $-10.30B | $2.50B | 3 month · $16.79M |
| 2025-12-31 | $0.00 | $40.00K | $12.79B | $2.65M | $-10.21B | $2.58B | (m) |
| 2025-09-30 | $0.00 | $36.00K | $12.35B | $2.46M | $-10.11B | $2.24B | 3 month · $14.14M |
| 2025-06-30 | $0.00 | $36.00K | $12.34B | $2.30M | $-10.02B | $2.31B | 3 month · $14.32M |
| 2025-03-31 | $0.00 | $35.00K | $12.32B | $1.67M | $-9.91B | $2.41B | 3 month · $16.26M |
| 2024-12-31 | $0.00 | $34.00K | $12.31B | $1.45M | $-9.80B | $2.50B | 12 month · $31.93M |
| 2024-09-30 | $0.00 | $33.00K | $12.29B | $2.19M | $-9.71B | $2.59B | 3 month · $17.40M |
| 2024-06-30 | $0.00 | $31.00K | $12.27B | $1.39M | $-9.58B | $2.70B | 3 month · $796.00K |
| 2023-12-31 | (m) | (m) | (m) | $1.07M | $-7.78B | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |